PhRMA Speculates Medicare Debate May Carry Over Until 2001
Executive Summary
The 106th Congress may be a "set-up" Congress for Medicare reform and drug benefit discussions after the next Presidential election, Pharmaceutical Research and Manufacturers of America President Alan Holmer told a Jan. 15 press briefing in Washington, D.C.
You may also be interested in...
PhRMA Moves To Head Off Clinton Assault; Considers Incremental Rx Benefit
The Pharmaceutical Research & Manufacturers of America is attempting to defuse some of the Clinton Administration's rhetoric on drug costs to the elderly ahead of the State of the Union address.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011